Table 2. Predicted and measured glycated hemoglobin and glycated albumin levels at the first and the third visits in groups divided according to diabetes treatments.
| Diabetes treatment | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|
| Diet | OHA | Insulin | Insulin followed by OHA | |
| n (Male/female) | 5 (3/2) | 17 (5/12) | 17 (8/9) | 15 (12/3) |
| Age (years) | 58.0 ± 15.2 | 64.4 ± 8.7 | 55.8 ± 18.5 | 62.1 ± 12.8 |
| Measured A1C at first visit (%) | 9.8 ± 1.9 | 10.7 ± 1.7 | 11.9 ± 2.0 | 11.8 ± 2.5 |
| Measured GA at first visit (%) | 26.2 ± 4.6 | 30.3 ± 7.1 | 36.6 ± 8.4 | 37.6 ± 10.5 |
| Measured A1C at third visit (%) | 7.9 ± 0.9 | 8.7 ± 0.9 | 8.8 ± 1.0 | 8.4 ± 1.3 |
| Measured GA at third visit (%) | 18.6 ± 1.4 | 20.3 ± 2.4 | 19.6 ± 3.2 | 18.7 ± 3.3 |
| Predicted A1C at third visit (%) | 8.1 ± 1.4 | 8.8 ± 1.1 | 8.6 ± 1.1 | 8.3 ± 1.5 |
| Predicted GA at third visit (%) | 18.2 ± 2.6 | 20.0 ± 2.8 | 18.7 ± 2.3 | 17.9 ± 2.7 |
| Measured/predicted A1C (%)† | 98 ± 8 | 98 ± 8 | 103 ± 10 | 102 ± 9 |
| Measured/predicted GA (%)† | 100 ± 10 | 101 ± 8 | 105 ± 16 | 104 ± 11 |
Data are means ± SD. †Values at the third visit. A1C, glycated hemoglobin; GA, glycated albumin; OHA, oral hypoglycemic agent.